64139-9
Butalbital/Creatinine [Mass Ratio] in Urine
Active
Part Descriptions
LP15046-3 Butalbital
Barbiturates were first developed in 1864 by Adolf von Baeyer and were widely distributed by the Farbwerke Fr Bayer and Co in 1904. Barbiturates offered new treatment to patients with psychiatric and neurological disorders profoundly improving their prognoses. Barbiturates were also used to treat sleep disorders and were the first drugs to effectively treat epileptic seizures. Due to safety concerns related to drug dependence and overdose and new safer psychoactive medications barbiturate use sharply declined in the 1950s. PMID: 18568113 Butalbital, in conjunction with aspirin, acetaminophen and/or caffeine, is used to treat migraine and tension-type headaches. The use of butalbital can lead to intoxication, hangover, tolerance, dependence and toxicity. Patients on high doses of butalbital may experience withdrawal upon discontinuing the drug. PMID: 11903523
Source: Regenstrief LOINC
LP32035-5 Creatinine
Creatinine or creatine anhydride, is a breakdown product of creatine phosphate in muscle. The loss of water molecule from creatine results in the formation of creatinine. It is transferred to the kidneys by blood plasma, whereupon it is eliminated by glomular filtration and partial tubular excretion. Creatinine is usually produced at a fairly constant rate and measuring its serum level is a simple test. A rise in blood creatinine levels is observed only with marked damage to functioning nephrons; therefore this test is not suitable for detecting early kidney disease. Creatine and creatinine are metabolized in the kidneys, muscle, liver and pancreas.
Copyright Copyright ©2005-2009 Genome Alberta (Reference to original publication: Wishart DS, Knox C, Guo AC, et al. HMDB: a knowledgebase for the human metabolome. Nucleic Acids Res. 2009 37(Database issue):D603-610.)
Source: Human Metabolome Database, Creatinine
Fully-Specified Name
- Component
- Butalbital/Creatinine
- Property
- MRto
- Time
- Pt
- System
- Urine
- Scale
- Qn
- Method
Additional Names
- Long Common Name
- Butalbital/Creatinine [Mass Ratio] in Urine
- Short Name
- Butalbital/Creat Ur
- Display Name
- Butalbital/Creatinine (U) [Mass ratio]
- Consumer Name Alpha Get Info
- Butalbital/Creatinine, Urine
Basic Attributes
- Class
- DRUG/TOX
- Type
- Laboratory
- First Released
- Version 2.36
- Last Updated
- Version 2.73
- Order vs. Observation
- Both
- Common Test Rank Get Info
- 4428
Language Variants Get Info
Tag | Language | Translation |
---|---|---|
es-ES | Spanish (Spain) | Butalbital/Creatinina: Synonyms: Cuantitativo |
es-MX | Spanish (Mexico) | Butalbital / Creatinina: |
fr-CA | French (Canada) | Bultalbital/Créatinine: |
fr-FR | French (France) | Butalbital/créatinine: |
fr-BE | French (Belgium) | Bultalbital/Créatinine: Synonyms: Rapport de masse |
it-IT | Italian (Italy) | Butalbitale/Creatinina: Synonyms: Livelli farmacologici e tossicologia Punto nel tempo (episodio) Rapporto di Massa |
nl-NL | Dutch (Netherlands) | butalbital/creatinine: Synonyms: kreatinine |
ru-RU | Russian (Russian Federation) | Буталбитал/Креатинин: Synonyms: Количественный Масс отношение Точка во времени; |
tr-TR | Turkish (Turkey) | Butalbital/Kreatinin: |
zh-CN | Chinese (China) | 布他比妥/肌酐: Synonyms: CR; |
Example Units
Unit | Source |
---|---|
ng/mg{creat} | Example UCUM Units |
LOINC Terminology Service (API) using HL7® FHIR® Get Info
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
- CodeSystem lookup
- https:
//fhir.loinc.org/CodeSystem/$lookup?system=http: //loinc.org&code=64139-9
LOINC Copyright
Copyright © 2024 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright © Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. See https://